138 related articles for article (PubMed ID: 8998156)
1. Evaluation of fulminant hepatic failure by scintigraphy with technetium-99m-GSA.
Shiomi S; Kuroki T; Kuriyama M; Takeda T; Nishiguchi S; Nakajima S; Tanaka T; Ochi H
J Nucl Med; 1997 Jan; 38(1):79-82. PubMed ID: 8998156
[TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of scintigraphy with 99mTc-galactosyl-human serum albumin for prognosis of cirrhosis of the liver.
Sasaki N; Shiomi S; Iwata Y; Nishiguchi S; Kuroki T; Kawabe J; Ochi H
J Nucl Med; 1999 Oct; 40(10):1652-6. PubMed ID: 10520705
[TBL] [Abstract][Full Text] [Related]
3. Clinical need for both scintigraphy with technetium-99m GSA and per-rectal portal scintigraphy in some patients with chronic liver disease.
Shiomi S; Iwata Y; Sasaki N; Kurooka H; Tamori A; Habu D; Takeda T; Nishiguchi S; Kuroki T; Ochi H
Ann Nucl Med; 1999 Aug; 13(4):241-5. PubMed ID: 10510880
[TBL] [Abstract][Full Text] [Related]
4. Fulminant hepatic failure monitored by technetium-99m-DTPA-galactosyl-human serum albumin scintigraphy.
Shiomi S; Kuroki T; Enomoto M; Ueda T; Masaki K; Ikeoka N; Takeda T; Kobayashi K; Ochi H
J Nucl Med; 1996 Apr; 37(4):641-3. PubMed ID: 8691258
[TBL] [Abstract][Full Text] [Related]
5. Use of scintigraphy with 99mtechnetium galactosyl human serum albumin for staging of primary biliary cirrhosis and assessment of prognosis.
Shiomi S; Sasaki N; Tamori A; Habu D; Takeda T; Nishiguchi S; Kuroki T; Kawabe J; Ochi H
J Gastroenterol Hepatol; 1999 Jun; 14(6):566-71. PubMed ID: 10385066
[TBL] [Abstract][Full Text] [Related]
6. [Clinical application of asialoglycoprotein receptor-mediated liver scintigraphy using 99mTc-DTPA-galactosyl-human serum albumin].
Ha-Kawa SK; Nakanishi Y; Kojima M; Tanaka Y; Kitagawa S; Kubota Y; Inoue K; Ikekubo K
Nihon Igaku Hoshasen Gakkai Zasshi; 1991 Dec; 51(12):1489-97. PubMed ID: 1792157
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m GSA scintigraphy within the first 3 days after admission as an early predictor of outcome in severe acute liver injury.
Suzuki Y; Kakisaka K; Sato T; Mikami R; Abe H; Sasaki T; Takikawa Y
Sci Rep; 2021 Jun; 11(1):12518. PubMed ID: 34131241
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of hepatic scintigraphy using 99mTc-GSA].
Ishii K; Nishiyama S; Nishimaki H; Tadokoro K; Ikeda T; Matsubayashi T; Ishii K
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Jun; 52(6):818-29. PubMed ID: 1641314
[TBL] [Abstract][Full Text] [Related]
9. Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT.
Hwang EH; Taki J; Shuke N; Nakajima K; Kinuya S; Konishi S; Michigishi T; Aburano T; Tonami N
J Nucl Med; 1999 Oct; 40(10):1644-51. PubMed ID: 10520704
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of hepatic function with (99m)Tc-galactosylated serum albumin scintigraphy in patients with malaria: comparison with (99m)Tc-colloid scintigraphy and liver ultrasonography.
Lee SW; Lee J; Lee DY; Chun KA; Ahn BC; Kang YM; Lee K
Nucl Med Commun; 2007 Feb; 28(2):95-9. PubMed ID: 17198349
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphic study of regenerative nodules due to fulminant hepatic failure.
Watanabe T; Kondo M; Hirasa M; Shirane H; Okabe Y; Ibuki Y; Tomita S; Orino A; Todo A; Wakatsuki Y; Chiba T; Kudo M
J Gastroenterol; 2003; 38(7):695-9. PubMed ID: 12898364
[TBL] [Abstract][Full Text] [Related]
12. A simplified method for the quantitative analysis of 99Tc(m)-GSA liver scintigraphy using spectral analysis.
Murase K; Tsuda T; Mochizuki T; Ikezoe J
Nucl Med Commun; 1998 Mar; 19(3):219-27. PubMed ID: 9625496
[TBL] [Abstract][Full Text] [Related]
13. [A study of acquisition time using compartment analysis with 99mTc-GSA liver scintigraphy].
Shinohara H; Niio Y; Hasebe S; Matuoka S; Oobuchi M; Higashi TS; Yamada M; Takagi T; Takizawa K; Suzuki S
Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Nov; 55(14):972-9. PubMed ID: 8570394
[TBL] [Abstract][Full Text] [Related]
14. [Phase II clinical study on 99mTc-GSA, a new agent for functional imaging of the liver].
Torizuka K; Ha-Kawa SK; Kudo M; Kitagawa S; Kubota Y; Tanaka Y; Hino M; Ikekubo K
Kaku Igaku; 1992 Jan; 29(1):85-95. PubMed ID: 1578824
[TBL] [Abstract][Full Text] [Related]
15. Hepatic functional reserve in patients with biliary malignancies: an assessment by technetium 99m galactosyl human serum albumin hepatic scintigraphy.
Fukunaga K; Todoroki T; Takada Y; Otsuka M; Kawamoto T; Fukao K
Int Surg; 1999; 84(3):199-203. PubMed ID: 10533776
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-DTPA-galactosyl human serum albumin liver scintigraphy evaluation of regional CT/MRI attenuation/signal intensity differences.
Akaki S; Mitsumori A; Kanazawa S; Togami I; Takeda Y; Joja I; Hiraki Y
J Nucl Med; 1998 Mar; 39(3):529-32. PubMed ID: 9529304
[TBL] [Abstract][Full Text] [Related]
17. [Clinical application of 99mTc-DTPA-galactosyl serum albumin in hepatobiliary disease].
Ohno K; Itoh K; Nagao K; Katoh H; Okushiba T; Satoh M; Tomiyama M; Hiraguchi E; Tanabe T
Kaku Igaku; 1993 Feb; 30(2):217-24. PubMed ID: 8468807
[TBL] [Abstract][Full Text] [Related]
18. [The utility of quantitative 99mTc-GSA liver scintigraphy in the evaluation of hepatic functional reserve: comparison with 99mTc-PMT and 99mTc-Sn colloid].
Shuke N; Aburano T; Nakajima K; Yokoyama K; Sun BF; Matsuda H; Muramori A; Michigishi T; Tonami N; Hisada K
Kaku Igaku; 1992 May; 29(5):573-84. PubMed ID: 1434071
[TBL] [Abstract][Full Text] [Related]
19. A quantitative model of technetium-99m-DTPA-galactosyl-HSA for the assessment of hepatic blood flow and hepatic binding receptor.
Ha-Kawa SK; Tanaka Y
J Nucl Med; 1991 Dec; 32(12):2233-40. PubMed ID: 1744708
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of usefulness of Tc-99m-GSA liver scintigraphy in chronic liver diseases].
Fukui H; Kashiwagi T; Kasahara A; Hiramatsu N; Matsunaga T; Oshita M; Goto M; Takei Y; Hayashi N; Kawano S
Kaku Igaku; 1991 Nov; 28(11):1333-41. PubMed ID: 1770648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
